Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.43 |
| ▸ | PARP1 | P09874 | 8/20 | 0.38 |
| ▸ | CDC7 | O00311 | 8/20 | 0.35 |
| ▸ | PIM1 | P11309 | 4/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 4/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 4/20 | 0.35 |
| ▸ | CIT | O14578 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.35 |
| ▸ | TAOK3 | Q9H2K8 | 1/20 | 0.35 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.34 |
| ▸ | CDK2 | P24941 | 4/20 | 0.34 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.34 |
| ▸ | DBF4 | Q9UBU7 | 4/20 | 0.34 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12404403 | 0.88 | SCN10A (0.56) | SCN10APARP1CDC7PIM1CSNK2B | |
| SCHEMBL10182844 | 0.87 | SCN10A (0.47) | SCN10APARP1CDC7PIM1CSNK2B | |
| SCHEMBL15045647 | 0.86 | SCN10A (0.54) | SCN10APARP1CDC7DYRK1ACCNE1 | |
| SCHEMBL10201770 | 0.84 | SCN10A (0.41) | SCN10APARP1CDC7PIM1CSNK2B | |
| SCHEMBL15045512 | 0.83 | SCN10A (0.47) | SCN10APARP1CDC7DYRK1ACCNE1 | |
| SCHEMBL12403409 | 0.82 | AAK1 (0.31) | — | |
| SCHEMBL15045511 | 0.81 | SCN10A (0.47) | SCN10APARP1CDC7PIM1CSNK2B | |
| SCHEMBL10202375 | 0.80 | SCN10A (0.55) | SCN10APARP1CDC7PIM1CSNK2B | |
| SCHEMBL10202371 | 0.79 | SCN10A (0.54) | SCN10APARP1CDC7PIM1CSNK2B | |
| SCHEMBL13561572 | 0.78 | SCN10A (0.44) | SCN10APARP1CDC7PIM1CSNK2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100215616-A1 | Hepatitis C Virus Inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100215616-A1 | Hepatitis C Virus Inhibitors | HAVCR2, PYGL, HCCS | SCN10A 4625/4885PARP1 3489/4885CDC7 911/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.